Skip to main content
Springer logoLink to Springer
. 2022 Nov 21;50(3):970. doi: 10.1007/s00259-022-06039-6

Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

Matthias Totzeck 1, Nicolas Aide 2, Johann Bauersachs 3, Jan Bucerius 4, Panagiotis Georgoulias 5, Ken Herrmann 6, Fabien Hyafil 7, Jolanta Kunikowska 8, Mark Lubberink 9, Carmela Nappi 10, Tienush Rassaf 1, Antti Saraste 11, Roberto Sciagra 12, Riemer HJA Slart 13,14, Hein Verberne 15, Christoph Rischpler 6,
PMCID: PMC9852205  PMID: 36409318

Correction to : European Journal of Nuclear Medicine and Molecular Imaging

https://doi.org/10.1007/s00259-022-05991-7

The authors regret that their names in the original article are incorrect as the first and last names were interchanged. It is now corrected in this erratum article.

The original article can be found at https://doi.org/10.1007/s00259-022-05991-7.

Footnotes

This article is part of the Topical Collection on Erratum.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from European Journal of Nuclear Medicine and Molecular Imaging are provided here courtesy of Springer

RESOURCES